Inflammasome-mediated corneal epithelial cell defenses inhibited by pathogenic bacteria
Inflammasome-mediated corneal epithelial cell defenses inhibited by pathogenic bacteria
批准号:
10502998
负责人:
Abby R Kroken
金额:
$37.73万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-04-30
关键词:
ADP Ribose TransferasesApoptosisBacteriaBypassCRISPR/Cas technologyCaspaseCell LineCellsCessation of lifeCicatrixClinicalContact LensesCorneaCorneal OpacityCorneal StromaCultured CellsCytoplasmDataDefense MechanismsEpithelialEpithelial CellsExotoxinsEyeEye InfectionsFilmHela CellsHost DefenseHost Defense MechanismHydrophilic Contact LensesImageImmuneImmune responseInfectionInflammasomeInflammatoryInjectionsInterleukin-1 betaInvadedKeratitisKnockout MiceLife StyleLinkLipopolysaccharidesLyticMeasuresMediatingMicrobeModelingMolecularMonitorMusNeutrophil InfiltrationOutcomePathogenicityPathway interactionsPredispositionProcessProductionPseudomonas aeruginosaPseudomonas aeruginosa infectionPublicationsResolutionRoleSiteSurfaceTestingTimeTissuesToxinTransformed Cell LineVirulence FactorsVisioncell typecorneal epitheliumcytokineexperimental studyimaging modalitymicrobialmouse modelmutantnovelocular surfacepathogenpathogenic bacteriapreventrecruitresponse
中文摘要
项目摘要/摘要
健康的角膜上皮是抵御病原菌和环境细菌的有效屏障。因为.
这一点,角膜感染或角膜炎模型通常依赖于通过引入
微生物直接进入角膜基质,在那里它们启动免疫细胞反应,从而破坏组织
并造成威胁视力的疤痕。这种实验方法的一个局限性是上皮防御
机制无法确定或调查。致病菌铜绿假单胞菌是
最常见的感染与戴软性隐形眼镜有关,这表明它是唯一能够引起
即使在上皮完好的情况下,间质也会受到感染。铜绿假单胞菌殖民的一种方式
上皮是通过在上皮细胞内侵入和复制,这已经在培养细胞中进行了研究,
并在小鼠角膜感染模型上进行观察。初步数据表明,该菌产生的EXOS毒素。
铜绿假单胞菌抑制caspase-4介导的侵袭性角膜上皮细胞下垂,为
细菌在受保护的小生境中复制。更多数据表明,另一条不同的炎症体途径是
在角膜上皮细胞中也很活跃,并导致细胞因子IL-1β的产生,它也是EXOS
抑制。因此,exos在角膜感染中的一个新作用可能是延长细菌的生态位
在角膜上皮细胞内复制,同时限制招募免疫细胞的细胞因子的分泌。vbl.使用
选择性监测侵袭细胞的成像方法和CRISPR-Cas9操纵角膜上皮细胞的方法
在遗传学方面,我们将回答关于角膜上皮防御和细菌的三个悬而未决的问题
颠覆:1.EXOS如何阻断caspase-4介导的下垂?2.角膜上皮细胞如何
检测和应对铜绿假单胞菌?3.上皮细胞炎性小体激活和
上睑下垂在保护眼睛免受基质中发生角膜炎的作用?圆满完成这些目标
将识别一种新的眼表宿主防御机制,进一步加深我们对
上皮细胞中的炎性小体,并阐明一种独特的破坏性角膜病原体如何能够
克服主机防御。
英文摘要
Project Summary/Abstract
The healthy corneal epithelium is an effective barrier to pathogenic and environmental bacteria. Because of
this, corneal infection or keratitis models often rely on bypassing the epithelium altogether by introducing
microbes directly into the corneal stroma, where they initiate immune cell responses that can damage tissue
and cause vision-threatening scarring. A limitation of this experimental approach is that epithelial defense
mechanisms are unable to be identified or investigated. The bacterial pathogen Pseudomonas aeruginosa is
the most common infection associated with soft contact lens wear, suggesting it is uniquely capable of causing
infection in the stroma even when the epithelium remains intact. One way in which P. aeruginosa colonizes the
epithelium is by invading and replicating inside epithelial cells, which has been investigated in cultured cells,
and observed in mouse corneal infection models. Preliminary data show that the toxin ExoS produced by P.
aeruginosa suppresses caspase-4 mediated pyroptosis of invaded corneal epithelial cells, buying time for
bacteria to replicate in a protected niche. Additional data indicate that a different inflammasome pathway is
also active in corneal epithelial cells, and leads to production of the cytokine IL-1β, which ExoS also
suppresses. Therefore, a novel role for ExoS in corneal infection could be to prolong a niche for bacteria to
replicate within corneal epithelial cells, while limiting secretion of cytokines that recruit immune cells. Using
imaging methods to selectively monitor invaded cells, and CRISPR-Cas9 to manipulate corneal epithelial cells
genetically, we will answer three outstanding questions regarding both corneal epithelial defense, and bacterial
subversion of it: 1. How does ExoS block caspase-4-mediated pyroptosis? 2. How do corneal epithelial cells
detect and respond to P. aeruginosa? 3. What is the significance of epithelial cell inflammasome activation and
pyroptosis in protecting the eye from developing keratitis in the stroma? Successful completion of these aims
will identify a new mechanism of host defense at the ocular surface, further our understanding of
inflammasomes in epithelial cells, and elucidate how a uniquely devastating corneal pathogen is able to
overcome host defenses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inflammasome-mediated corneal epithelial cell defenses inhibited by pathogenic bacteria
-
批准号:10688090
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2022
-
负责人:Abby R Kroken
-
依托单位:
Corneal infection: bacterial localization versus virulence
-
批准号:8983859
-
项目类别:
-
资助金额:$5.42万
-
财政年份:2015
-
负责人:Abby R Kroken
-
依托单位:
Corneal infection: bacterial localization versus virulence
-
批准号:9313891
-
项目类别:
-
资助金额:$6.1万
-
财政年份:2015
-
负责人:Abby R Kroken
-
依托单位:
Corneal infection: bacterial localization versus virulence
-
批准号:9169926
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2015
-
负责人:Abby R Kroken
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: